These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17719313

  • 1. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 2. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 3. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.
    Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947
    [Abstract] [Full Text] [Related]

  • 4. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 5. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 6. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
    Sisakian AS, Torgomian AL, Barkhudarian AL.
    Klin Med (Mosk); 2006 Nov; 84(10):55-8. PubMed ID: 17201276
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 8. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E, Ozdemir R, Barutcu I, Aksoy Y, Sincer I, Akturk E, Cehreli S.
    J Electrocardiol; 2006 Apr 05; 39(2):211-8. PubMed ID: 16580422
    [Abstract] [Full Text] [Related]

  • 9. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr 05; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 10. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct 05; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
    Fernández-Reyes MJ, Mon C, Heras M, Guevara P, Garcia MC, Sanchez R, Velasco S, Alvarez-Ude F.
    J Nephrol; 2004 Oct 05; 17(5):721-7. PubMed ID: 15593041
    [Abstract] [Full Text] [Related]

  • 12. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M, Dernek S, Sevin B, Kural T.
    Anadolu Kardiyol Derg; 2003 Dec 05; 3(4):303-8. PubMed ID: 14675878
    [Abstract] [Full Text] [Related]

  • 13. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec 05; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 14. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R.
    Rev Port Cardiol; 2000 Nov 05; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [Abstract] [Full Text] [Related]

  • 15. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.
    Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770
    [Abstract] [Full Text] [Related]

  • 16. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.
    Ohba H, Takada H, Musha H, Nagashima J, Mori N, Awaya T, Omiya K, Murayama M.
    Am Heart J; 2001 May 09; 141(5):751-8. PubMed ID: 11320362
    [Abstract] [Full Text] [Related]

  • 17. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT.
    Am J Cardiol; 2009 Jan 01; 103(1):73-5. PubMed ID: 19101233
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O, Gwizdała A, Katarzyński S, Katarzyńska A, Szyszka A, Lanocha M, Grajek S, Kramer L.
    Cardiol J; 2009 Jan 01; 16(2):133-41. PubMed ID: 19387960
    [Abstract] [Full Text] [Related]

  • 19. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC, Jaffe AS.
    Circulation; 2007 Jul 17; 116(3):249-57. PubMed ID: 17592074
    [Abstract] [Full Text] [Related]

  • 20. Use of B-type natriuretic peptide in the detection of myocardial ischemia.
    Staub D, Nusbaumer C, Zellweger MJ, Jonas N, Wild D, Pfisterer ME, Mueller-Brand J, Perruchoud AP, Mueller C.
    Am Heart J; 2006 Jun 17; 151(6):1223-30. PubMed ID: 16781223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.